rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Cipla Ltd.

500087 CIPLA Group (A)

22 Jul,09:38
1477.15
-8.00 (-0.54%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Cipla Ltd.

BUYSELL
3,190 1,485.15 1,482.00 - 1,470.05 1,581.70 - 1,020.00 119,294.64
NSE | BSE

Cipla Ltd.

CIPLA

22 Jul,09:37
1476.85
-8.65 (-0.58%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Cipla Ltd.

BUYSELL
120,022 1485.5 1,482.00 - 1,470.65 1,582.00 - 1,027.00 1,772.42

News for Cipla Ltd.

Cipla Faces Rs...
Cipla Faces Rs 773 Crore I-T Demand: Details - Business News
Cipla receives a Rs 773.44 crore demand notice from the income tax department for assessment years 2015-16 to 2022-23. The company plans to appeal the order.
Jul 16, 2024 16:40
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Orchid Pharma &...
Orchid Pharma & Cipla Partner for New Antibiotic in India
Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...
Jun 28, 2024 19:42
Cipla Gets USFDA...
Cipla Gets USFDA Nod for Generic Lanreotide Injection
Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.
May 22, 2024 12:13
Cipla Promoters...
Cipla Promoters Sell 2.53% Stake for Rs 2,750 Cr | News
Cipla promoters offload 2.53% stake for Rs 2,750 crore to create liquidity for philanthropy and other needs. The deal was completed through a block deal on the NSE, with buyers including Aditya...
May 15, 2024 19:25

More News for Cipla Ltd. »

(Rs. Crore)

Financial Results of Cipla Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales16,574.3415,790.6013,091.7913,900.5812,659.15
Operating profit4,484.153,792.583,366.473,721.562,707.29
Interest20.2527.0226.9345.0736.05
Gross profit5,534.564,222.354,006.243,906.773,564.09
EPS (Rs)50.5031.1436.6630.6128.75

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Cipla Ltd.

Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia

News for Pharmaceuticals and health care

Wipro Shares...
Wipro Shares Plunge 9% After Earnings: Flat Growth Guidance
Wipro shares plummeted nearly 9% on Monday after the IT major announced flat sequential growth guidance for the upcoming quarter. The company reported a 4.6% YoY rise in net profit but saw a...
Jul 22, 2024 10:20
NBFC-PSL Category...
NBFC-PSL Category for MSMEs: Key Budget Demand
Business leaders urge the creation of a new NBFC-PSL category in the Union Budget to boost MSME lending and growth.
Jul 22, 2024 10:17
Indian Markets...
Indian Markets Tank: Reliance, Kotak Drag, Global Weakness
Indian stock markets opened lower on Monday, with Reliance Industries and Kotak Mahindra Bank leading the decline, mirroring weak global trends. Sensex fell by 504 points and Nifty dropped 168 points.
Jul 22, 2024 09:51
Purabi Dairy to...
Purabi Dairy to Operate Assam Govt Dairy Plant
Purabi Dairy has partnered with the Assam government to operate a 5,000-liter daily capacity dairy plant in Dhemaji district, boosting the dairy sector in upper Assam.
Jul 21, 2024 19:47
IT Union...
IT Union Criticizes HCL's New Leave Policy
NITES, an IT workers' union, has criticized HCL Technologies' new policy linking leaves to office attendance, calling it unfair and urging the company to reconsider. The policy mandates at least 12...
Jul 21, 2024 19:21

More News »

Top News

Wipro Shares...
Wipro Shares Plunge 9% After Earnings: Flat Growth Guidance
Wipro shares plummeted nearly 9% on Monday after the IT major announced flat sequential growth guidance for the upcoming quarter. The company reported a 4.6% YoY rise in net profit but saw a...
Jul 22, 2024 10:20
NBFC-PSL Category...
NBFC-PSL Category for MSMEs: Key Budget Demand
Business leaders urge the creation of a new NBFC-PSL category in the Union Budget to boost MSME lending and growth.
Jul 22, 2024 10:17
China Cuts...
China Cuts Interest Rates to Boost Economy
China's central bank has cut interest rates to revive the property sector and stimulate economic growth, aiming to counter a slowdown.
Jul 22, 2024 09:57
Indian Markets...
Indian Markets Tank: Reliance, Kotak Drag, Global Weakness
Indian stock markets opened lower on Monday, with Reliance Industries and Kotak Mahindra Bank leading the decline, mirroring weak global trends. Sensex fell by 504 points and Nifty dropped 168 points.
Jul 22, 2024 09:51
Rupee Recovers From All-Time Low, Rises 5 Paise to 83.65 Against US Dollar
The Indian rupee recovered 5 paise against the US dollar in early trade on Monday, as the American currency retreated from its elevated level. Foreign fund inflows and possible intervention by the...
Jul 22, 2024 09:40

More Top News »

Report Card

PE Ratios
29.38
EPS (Rs.)
50.50
Sales (Rs. Cr)
4,036.66
Face Value (Rs.)
2
Net Profit Margin (%)
15.91
Last Bonus
3:2
Last Dividend(%)
650
Return on Average Equity
10.21

BSE Announcements from Cipla Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 3 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 4 day(s) ago

Compare 'Cipla Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I am retired pensioner at 53 years of age with...

Hello sir, I am 23 years old, just graduated and...

Hi, I want to understand about SWP mutual fund...

Hello Sir, I plan to invest in the following funds...

Sir My age is 53. My PF contribution from salary is...

I am 66, my annual income is 8 lacs. What are the...

More REDIFFGURUS

RediffGurus

Money question

I am 79 yrs old and most of my investments are in...

Cipla Ltd. performance snapshot

If you had invested Rs.  in Cipla Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Cipla Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Cipla Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Cipla Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close